Combined-modality treatment for advanced oral tongue squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 2, 2007, Pages 453-461

  Fan, Kang Hsing ^a   Lin, Chen Yu ^a   Kang, Chung Jan ^a   Huang, Shiang Fu ^a   Wang, Hung Ming ^a,b   Chen, Eric Yen Chao ^a   Chen, I How ^a   Liao, Chun Ta ^a   Cheng, Ann Joy ^a   Chang, Joseph Tung Chieh ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Combined modality therapy; Concurrent chemotherapy; Radiotherapy; Tongue neoplasms

Indexed keywords

BIOMEDICAL ENGINEERING; CHEMOTHERAPY; GROWTH KINETICS; RADIOTHERAPY; TUMORS;

CELL CARCINOMA; COMBINED MODALITY THERAPY; CONCURRENT CHEMOTHERAPY; TONGUE NEOPLASMS;

CELLS;

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIFFERENTIATION; DISEASE FREE SURVIVAL; EXCISION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 33846233817     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.06.026     Document Type: Article

References (31)

1. Alvi A., and Johnson J.T. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 19 (1997) 500-505
2. Greenberg J.S., Fowler R., Gomez J., et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97 (2003) 1464-1470
3. Myers J.N., Greenberg J.S., Mo V., et al. Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92 (2001) 3030-3036
4. Hosal A.S., Unal O.F., and Ayhan A. Possible prognostic value of histopathologic parameters in patients with carcinoma of the oral tongue. Eur Arch Otorhinolaryngol 255 (1998) 216-219
5. Sessions D.G., Spector G.J., Lenox J., et al. Analysis of treatment results for oral tongue cancer. Laryngoscope 112 (2002) 616-625
6. Unal O.F., Ayhan A., and Hosal A.S. Prognostic value of p53 expression and histopathological parameters in squamous cell carcinoma of oral tongue. J Laryngol Otol 113 (1999) 446-450
7. Greenberg J.S., El Naggar A.K., Mo V., et al. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer 98 (2003) 508-515
8. Dimery I.W., and Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85 (1993) 95-111
9. Fletcher G.H., and Evers W.T. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 95 (1970) 185-188
10. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
11. Mishra R.C., Singh D.N., and Mishra T.K. Post-operative radiotherapy in carcinoma of buccal mucosa, a prospective randomized trial. Eur J Surg Oncol 22 (1996) 502-504
12. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26 (1993) 3-11
13. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
14. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
15. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
16. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 (2005) 843-850
17. Johnson R.E., Sigman J.D., Funk G.F., et al. Quantification of surgical margin shrinkage in the oral cavity. Head Neck 19 (1997) 281-286
18. Wei F.C., Jain V., Celik N., et al. Have we found an ideal soft-tissue flap?. An experience with 672 anterolateral thigh flaps. Plast Reconstr Surg 109 (2002) 2219-2226 discussion 2227-2230
19. Looser K.G., Shah J.P., and Strong E.W. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg 1 (1978) 107-111
20. Zelefsky M.J., Harrison L.B., Fass D.E., et al. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 25 (1993) 17-21
21. Gorsky M., Epstein J.B., Oakley C., et al. Carcinoma of the tongue: a case series analysis of clinical presentation, risk factors, staging, and outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 546-552
22. Chen Y.K., Huang H.C., Lin L.M., et al. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 35 (1999) 173-179
23. Kantola S., Parikka M., Jokinen K., et al. Prognostic factors in tongue cancer-relative importance of demographic, clinical and histopathological factors. Br J Cancer 83 (2000) 614-619
24. Holm L.E., Lundquist P.G., Silfversward C., et al. Histological grading of malignancy in squamous cell carcinoma of the oral tongue. Acta Otolaryngol 94 (1982) 185-192
25. Lo W.L., Kao S.Y., Chi L.Y., et al. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 61 (2003) 751-758
26. Bachaud J.M., Cohen-Jonathan E., Alzieu C., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
27. Licitra L., Grandi C., Guzzo M., et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21 (2003) 327-333
28. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 60 (1987) 301-311
29. Laramore G.E., Scott C.B., al-Sarraf M., et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int J Radiat Oncol Biol Phys 23 (1992) 705-713
30. Robert F., Ezekiel M.P., Spencer S.A., et al. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer. J Clin Oncol 19 (2001) 3234-3243
31. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578